Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Longitudinal Examination of the Hopelessness Theory of Depression in People Who Have Multiple Sclerosis.
Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1.
Isolation of highly enriched primary human microglia for functional studies.
Physiological Role of K(+) Channels in the Regulation of T Cell Function.
Modeling the course and outcomes of MS is statistical twaddle-No.
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis.
Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis.
Caregiver burden in multiple sclerosis: A structured review of the instruments.
MRI lesions: a surrogate for relapses in multiple sclerosis?
IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Multiple sclerosis and pregnancy prescriptions.
Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis.
Evaluation and Treatment of Autoimmune Neurologic Disorders in the Pediatric Intensive Care Unit.
Two functional promoter polymorphisms of neuregulin 1 gene are associated with progressive forms of multiple sclerosis.
Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?
Decoding the substrate supply to human neuronal nitric oxide synthase.
Brain radiation and possible presentation of multiple sclerosis.
IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.
Teva to present further results of twenty-year open-label extension study of glatiramer acetate 20 mg daily for relapsing-remitting multiple sclerosis
Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.
Regional brain atrophy and functional connectivity changes related to fatigue in multiple sclerosis.
Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice.
Clinical and Radiological Characterization of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients: A Retrospective Analysis and Review of the Literature.
The Effect of Plasma Exchange on the Expression of FOXP3 and RORC2 in Relapsed Multiple Sclerosis Patients.
Pages
« first
‹ previous
…
604
605
606
607
608
609
610
611
612
…
next ›
last »